Skip to main content

Rigel Pharmaceuticals Inc

RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001034842

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Rigel Pharmaceuticals Inc changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of RIGL: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders123126+3
Shares13.9M13.9M−18.6K (−0.1%)
Value$250.2M$260.2M+$9.94M (+4.0%)

New holders (21)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to RIGL in Q2 2025
InstitutionSharesValue% of portfolio
LSV Asset Management95,700$1.79M0.00%
Brandywine Global Investment Management, LLC76,870$1.44M0.01%
Carrera Capital Advisors50,299$942.1K0.19%
Mackenzie Financial Corp37,827$708.5K0.00%
Sierra Summit Advisors LLC37,269$698.0K0.12%
Millennium Management LLC31,259$585.5K0.00%
Jump Financial, LLC23,022$431.2K0.01%
Arrowstreet Capital, Limited Partnership21,983$411.7K0.00%
Jane Street Group, LLC17,333$324.6K0.00%
American Century Companies Inc16,935$317.2K0.00%
Principal Financial Group Inc15,994$299.6K0.00%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main9,489$177.7K0.00%
RMG Wealth Management LLC2,205$41.5K0.01%
Truvestments Capital LLC877$16.4K0.00%
Raymond James Financial Inc100$1.87K0.00%
Federated Hermes, Inc.69$1.29K0.00%
Clearstead Advisors, LLC58$1.09K0.00%
True Wealth Design, LLC28$5250.00%
The PNC Financial Services Group, Inc.15$2810.00%
IFP Advisors, Inc0$2810.00%
Essential Partners LLC3$560.00%

Sold out (18)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q1 2025 and filed for Q2 2025 without it.